These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10783567

  • 1. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
    Nagamachi S, Jinnouchi S, Nishii R, Flores LG, Nakahara H, Futami S, Tamura S, Toshimori H, Kawai K.
    Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ.
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE, Gurll N, Schurrer ME, Aktay R, Kirchner PT.
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [Abstract] [Full Text] [Related]

  • 4. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D, Mazzarotto R, Casara D.
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinoma.
    Uğur O, Kostakoğlu L, Caner B, Güler N, Gülaldi NC, Ozmen M, Uysal U, Elahi N, Erbengi G, Bejdik C.
    Nucl Med Commun; 1996 May; 17(5):373-7. PubMed ID: 8736512
    [Abstract] [Full Text] [Related]

  • 6. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
    Küçük ON, Gültekin SS, Aras G, Ibiş E.
    Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
    [Abstract] [Full Text] [Related]

  • 7. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
    Miyamoto S, Kasagi K, Misaki T, Alam MS, Konishi J.
    J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
    [Abstract] [Full Text] [Related]

  • 9. Isotope imaging for metastatic thyroid cancer.
    Haugen BR, Lin EC.
    Endocrinol Metab Clin North Am; 2001 Jun; 30(2):469-92. PubMed ID: 11444171
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
    Fujie S, Okumura Y, Sato S, Akaki S, Katsui K, Himei K, Takemoto M, Kanazawa S.
    Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 14. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
    Casara D, Rubello D, Saladini G, Mazzarotto R, Sotti G, Tomasella G, Pelizzo MR.
    Tumori; 1999 May; 85(2):122-7. PubMed ID: 10363078
    [Abstract] [Full Text] [Related]

  • 15. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 May; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 16. Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma.
    Lin JD, Kao PF, Weng HF, Lu WT, Huang MJ.
    Eur J Nucl Med; 1998 Jul; 25(7):695-700. PubMed ID: 9662590
    [Abstract] [Full Text] [Related]

  • 17. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 18. The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hürthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans.
    Yen TC, Lin HD, Lee CH, Chang SL, Yeh SH.
    Eur J Nucl Med; 1994 Sep; 21(9):980-3. PubMed ID: 7995293
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O, Kostakğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel D, Aras T, Bayhan H, Bekdik C.
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.